GABA(B) receptors as potential targets for drugs able to prevent excessiveexcitatory amino acid transmission in the spinal cord

Citation
G. Bonanno et al., GABA(B) receptors as potential targets for drugs able to prevent excessiveexcitatory amino acid transmission in the spinal cord, EUR J PHARM, 362(2-3), 1998, pp. 143-148
Citations number
25
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
362
Issue
2-3
Year of publication
1998
Pages
143 - 148
Database
ISI
SICI code
0014-2999(199812)362:2-3<143:GRAPTF>2.0.ZU;2-G
Abstract
The effects of GABA, receptor activation on the Ca2+-dependent depolarizati on-induced overflow of endogenous glutamic acid and gamma-aminobutyric acid (GABA) was studied in rat spinal cord nerve terminals exposed in superfusi on to 15 mM KCl. The GABA, receptor agonist (-)-baclofen inhibited the K+-e voked overflow of glutamate (EC50 = 0.098 mu M) but was almost inactive aga inst that of GABA. The overflow of both transmitters could be quite similar ly inhibited by two other GABA(B) receptor agonists, 3-APPA (3-aminopropylp hosphonous acid; EC50 = 0.087 and 0.050 mu M in the case of GABA and glutam ate, respectively) and CGP 44532 (3-amino-2(S)-hydroxypropyl)methylphosphin ic acid (EC50 = 0.81 and 0.50 mu M). The GABA(B) receptor antagonist CGP 35 348 [3-amino-propyl(diethoxymethyl)phosphinic acid] blocked the effect of 3 -APPA (1 mu M) at the autoreceptors (IC50 = 1 mu M), but not at the heteror eceptors. In contrast, the effects of 3-APPA at both autoreceptors and hete roreceptors could be similarly prevented by another GABA, receptor antagoni st, CGP 52432 [3-[[(3,4-dichlorophenyl)methyl]amino]propyl](diethoxymethyl) phosphinic acid (IC50 similar or equal to 10 mu M). The data suggest that, in the spinal cord, GABA, autoreceptors on GABA-releasing terminals differ pharmacologically from GABA, heteroreceptors on glutamatergic terminals. S elective GABA, receptor ligands may be helpful for conditions characterized by excessive glutamatergic transmission in the spinal cord. (C) 1998 Elsev ier Science B.V. All rights reserved.